mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors

Future Virol. 2021 Aug:10.2217/fvl-2021-0166. doi: 10.2217/fvl-2021-0166. Epub 2021 Sep 2.

Authors

Emre Yekedüz^{1

2}, Rüveyda Ayasun^{2

3}, Elif Berna Köksoy^{1

2}, Güngör Utkan^{1

2}, Yüksel Ürün^{1

2}, Hakan Akbulut^{1

2}

Affiliations

¹ Department of Medical Oncology, Ankara University, Ankara, Turkey.
² Ankara University Cancer Research Institute, Ankara, Turkey.
³ Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey.

No abstract available

Keywords: COVID-19; SARS-CoV-2; cancer; immunotherapy; mRNA; vaccine.

Publication types

Editorial